Newsletter

Subscribe and receive updates on this company

Text STOCKS to 72727 for mobile alerts

We are excited to present Amexdrug Corp. (OTC: AXRX).

Full DD Report for AXRX

You must become a subscriber to view this report.


Recent News from (OTC: AXRX)

Natasha Amin of Amexdrug Corporation (OTC PINK: AXRX) Announced Today the Release of Two Potent Topical Over-the-Counter Drugs for Arthritis Pain Relief, Nail & Skin Anti-Fungal and One Natural Nail Formula for Yellow, Discolored Nails
Reluctant to Pop Another Pill? COMMERCE, CA / ACCESSWIRE / DECEMBER 6, 2016 / Natasha Amin, Chief Operating Officer of Amexdrug Corporation (OTC PINK: AXRX) eagerly announced through its subsidiary, BioRx Labs, a leading provider of innovative pharmaceuticals, the development and release...
Source: ACCESSWIRE IA
Date: December, 06 2016 09:01
BioRx Labs, a Subsidiary of Amexdrug Corporation, Announces Newly Intellectual Property Trademark and Registered High Quality Vial Products & Skincare Line
COMMERCE, CA / ACCESSWIRE / November 3, 2016 / Natasha Amin, Chief Operating Officer of Amexdrug Corporation (OTCMKTS:AXRX) announced the availability of the latest four innovative products to BioRx Labs, a subsidiary of Amexdrug Corporation. "We are thrilled to add new high-quality ...
Source: ACCESSWIRE IA
Date: November, 03 2016 15:58

 


About Amexdrug Corp. (OTC: AXRX)

Logo for Amexdrug Corp. (OTC: AXRX)

Not available

 

Contact Information

 

 

Current Management

  • Jack Amin / President, CEO, CFO
  • Gwen Duffy / Accountant

Current Share Structure

  • Market Cap: $15,246,866 - 03/14/2018
  • Authorized: 1,000,000,000 - 03/31/2016
  • Issue and Outstanding: 169,409,620 - 03/31/2016

 


Recent Filings from (OTC: AXRX)

Quarterly Report - Quarterly Report
Filing Type: Quarterly Report - Quarterly ReportFiling Source: OTC Markets
Filing Date: November, 15 2017
Quarterly Report - Quarterly Report
Filing Type: Quarterly Report - Quarterly ReportFiling Source: OTC Markets
Filing Date: August, 15 2017
Quarterly Report - Quarterly Report
Filing Type: Quarterly Report - Quarterly ReportFiling Source: OTC Markets
Filing Date: May, 20 2017
Notification of Late Filing - Notification of Late Filing
Filing Type: Notification of Late Filing - Notification of Late FilingFiling Source: OTC Markets
Filing Date: May, 16 2017
Annual Report - Annual Report
Filing Type: Annual Report - Annual ReportFiling Source: OTC Markets
Filing Date: April, 01 2017
Quarterly Report - Quarterly Report
Filing Type: Quarterly Report - Quarterly ReportFiling Source: OTC Markets
Filing Date: November, 17 2016
Notification of Late Filing - Notification of Late Filing
Filing Type: Notification of Late Filing - Notification of Late FilingFiling Source: OTC Markets
Filing Date: November, 15 2016
Quarterly Report - Quarterly Report
Filing Type: Quarterly Report - Quarterly ReportFiling Source: OTC Markets
Filing Date: August, 16 2016
Quarterly Report - Quarterly Report
Filing Type: Quarterly Report - Quarterly ReportFiling Source: OTC Markets
Filing Date: May, 22 2016
Notification of Late Filing - Notification of Late Filing
Filing Type: Notification of Late Filing - Notification of Late FilingFiling Source: OTC Markets
Filing Date: May, 17 2016

 

 


Daily Technical Chart for (OTC: AXRX)

Daily Technical Chart for (OTC: AXRX)


Stay tuned for daily updates and more on (OTC: AXRX)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: AXRX)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

Monsta Trader
@MonstaTrader

 

 


Disclaimer: Monsta Trader publishes reports providing information on selected companies. Monsta Trader is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. Monsta Trader accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in AXRX is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. Monsta Trader has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. Monsta Trader does not own any shares of AXRX and does not buy, sell, or trade any shares of AXRX. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by Monsta Trader. All rights reserved. Our Full Disclaimer: http://monstatrader.com/disclaimer/